September 26th 2025
COVID-19 vaccination in pregnancy reduced infection, stillbirth, and preterm birth risks without increased adverse maternal outcomes.
Meeting to discuss COVID-19 vaccine in kids 6 months to 4 years postponed
February 11th 2022The US Food and Drug Administration announces that the meeting to discuss extending the emergency use authorization for the Pfizer/BioNTech vaccine to children aged 6 months to 4 years has been postponed until data on a third dose has been studied.
COVID-19 vaccine exposure in utero not linked to adverse neonatal outcomes
February 11th 2022The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.
Does maternal history of cervical cancer/biopsy impact HPV vaccine rate in kids?
December 16th 2021For mothers who have an experience with human papillomavirus (HPV) vaccine preventable outcomes such as a cervical biopsy or cancer, would this history make them more likely to have their child receive this vaccine? It may seem likely, but a new study raises questions about this belief.